Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients.
Lee SJ, Park W, Park SH, Shim SC, Baek HJ, Yoo DH, Kim HA, Lee SK, Leee YJ, Park YE, Cha HS, Park JK, Lee EY, Lee EB, Song YW.
Lee SJ, et al. Among authors: park jk, park ye, park w, park sh.
J Immunol Res. 2015;2015:487230. doi: 10.1155/2015/487230. Epub 2015 Apr 2.
J Immunol Res. 2015.
PMID: 25922848
Free PMC article.
Clinical Trial.